These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 28710827)

  • 21. Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration.
    Ong SG; Lee WH; Zhou Y; Wu JC
    Methods Mol Biol; 2018; 1733():127-136. PubMed ID: 29435928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of two-pore K
    Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.
    Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP
    Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Cultured Human Cardiomyocyte Clusters Obtained from Embryos/Fetuses or Derived from Human Embryonic Stem Cells.
    Grubb S; Vestergaard ML; Andersen AS; Rasmussen KK; Mamsen LS; Tuckute G; Grunnet-Lauridsen K; Møllgård K; Ernst E; Christensen ST; Calloe K; Andersen CY
    Stem Cells Dev; 2019 May; 28(9):608-619. PubMed ID: 30755084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
    Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
    FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin.
    Lewandowski J; Rozwadowska N; Kolanowski TJ; Malcher A; Zimna A; Rugowska A; Fiedorowicz K; Łabędź W; Kubaszewski Ł; Chojnacka K; Bednarek-Rajewska K; Majewski P; Kurpisz M
    Cell Transplant; 2018 Jul; 27(7):1047-1067. PubMed ID: 29947252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
    PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models.
    Yu Y; Qin N; Lu XA; Li J; Han X; Ni X; Ye L; Shen Z; Chen W; Zhao ZA; Lei W; Hu S
    Stem Cell Res Ther; 2019 Jun; 10(1):167. PubMed ID: 31196181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.
    Liao SY; Liu Y; Siu CW; Zhang Y; Lai WH; Au KW; Lee YK; Chan YC; Yip PM; Wu EX; Wu Y; Lau CP; Li RA; Tse HF
    Heart Rhythm; 2010 Dec; 7(12):1852-9. PubMed ID: 20833268
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
    Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status.
    Chun YW; Voyles DE; Rath R; Hofmeister LH; Boire TC; Wilcox H; Lee JH; Bellan LM; Hong CC; Sung HJ
    J Biomech; 2015 Nov; 48(14):3890-6. PubMed ID: 26476764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium signalling of human pluripotent stem cell-derived cardiomyocytes.
    Li S; Chen G; Li RA
    J Physiol; 2013 Nov; 591(21):5279-90. PubMed ID: 24018947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
    Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
    Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
    Zhao M; Nakada Y; Wei Y; Bian W; Chu Y; Borovjagin AV; Xie M; Zhu W; Nguyen T; Zhou Y; Serpooshan V; Walcott GP; Zhang J
    Circulation; 2021 Jul; 144(3):210-228. PubMed ID: 33951921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect.
    Ye L; Yu Y; Zhao ZA; Zhao D; Ni X; Wang Y; Fang X; Yu M; Wang Y; Tang JM; Chen Y; Shen Z; Lei W; Hu S
    Cardiovasc Res; 2022 Feb; 118(3):859-871. PubMed ID: 33956078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.